Compliance
cGMPs

GlaxoSmithKline Bribery Scandal: Sexual Favors to Increase Sales?

July 18, 2013

China continues to step up its probe into alleged bribery by British drugmaker GlaxoSmithKline to illegally boost sales and inflate the price of its medicines.

Latest from cGMPs

Compliance fire drill: Mock FDA audits for cleaning validation

White paper: Enhancing virus clearance process capability using a biodegradable detergent

Key considerations for CGMP raw materials compliance

Intas hit with FDA warning letter

GlaxoSmithKline Bribery Scandal: Sexual Favors to Increase Sales?

Latest from cGMPs

Compliance fire drill: Mock FDA audits for cleaning validation

White paper: Enhancing virus clearance process capability using a biodegradable detergent

Key considerations for CGMP raw materials compliance

Intas hit with FDA warning letter

Beyond ‘good’ practices

Biocon hit with multiple 483s